CELZ — Creative Medical Technology Holdings Share News
0.000.00%
Last trade - 00:00- $4.88m
- -$3.81m
- $0.01m
Brief: Creative Medical Tech Announces Positive Top-Line Results For Type 2 Diabetes Study
Creative Medical surges on positive data from diabetes study
U.S. STOCKS ON THE MOVE-Manchester United, Verona Pharma, 89Bio
U.S. STOCKS ON THE MOVE-Ollie, Commercial Metals, Copper Aluminum miners
Creative Medical rises on filing for FDA's 'orphan drug' tag for diabetes treatment
Brief: Creative Medical Technology Files Orphan Drug Designation Application With The U.S. FDA Using The Immcelz® Platform For The Treatment Of Brittle Type 1 Diabetes
Brief: Creative Medical Technology Holdings Engages Highly Respected International Cro For Phase 1 / 2 Clinical Trial To Treat Type 1 Diabetes Using Celz-201
U.S. STOCKS ON THE MOVE-Packaged food makers, energy firms, Thomson Reuters
U.S. STOCKS ON THE MOVE-Ford Motor, Cleveland-Cliffs, Exelon Corp
Creative Medical rises on positive long-term data for StemSpine procedure
Brief: Creative Medical Technology Holdings Inc Announced Positive Three-Year Follow-Up Data For Company's Stemspine Pilot Study
U.S. STOCKS ON THE MOVE-Alibaba Group, TripAdvisor, MGM Resorts
U.S. STOCKS ON THE MOVE-Alphabet, Fox Corp, New York Times
Creative Medical rises on regulatory nod for therapy trials in Type 1 diabetes
Brief: Creative Medical Technology Announces IRB Approval For FDA Cleared Phase 1/2 Clinical Trial Of Novel Cell Therapy For The Treatment Of Type 1 Diabetes
U.S. STOCKS ON THE MOVE-Organon, Veracyte, InfuSystem
U.S. STOCKS ON THE MOVE-Ball Corp, 4D Molecular, AmerisourceBergen
Creative Medical up on U.S. FDA nod for diabetes therapy
Brief: Creative Medical Technology Announces FDA Clearance Of Investigational New Drug Application For AlloStem For Treatment Of Type 1 Diabetes